Literature DB >> 25041116

Analysis of novel mutations in BRCA1 in Iranian families with breast cancer.

Ariane Sadr-Nabavi1, Mahtab Dastpak, Fatemeh Homaei-Shandiz, Ahmad Reza Bahrami, Hamid-Reza Bidkhori, Mahmood Raeesolmohaddeseen.   

Abstract

In Iran and the rest of the world, breast cancer (BC) is the most common malignancy in women. Familial history and age are significant risk factors for the development of this disease in Iran. Most hereditary BCs are associated with inherited mutations in the BRCA1 and BRCA2 genes. Some recent studies demonstrated that BRCA1 mutations are seen in high-risk women with family histories of BC. In this report we investigated all BRCA1 exons from 40 female patients with family histories of BC and one BC twin, and report a novel mutation in this gene in one patient. As controls, BRCA1 exons from 100 normal women and the BC-free twin of the BC twin were also examined for this mutation. None of the women in the normal group harbored the mutation. Whether this variation is specific for the Iranian population or for special subgroups remains to be determined.
© 2014 The Authors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25041116     DOI: 10.1111/hrd2.00040

Source DB:  PubMed          Journal:  Hereditas        ISSN: 0018-0661            Impact factor:   3.271


  2 in total

1.  Clinical Variant Classification: A Comparison of Public Databases and a Commercial Testing Laboratory.

Authors:  William Gradishar; KariAnne Johnson; Krystal Brown; Erin Mundt; Susan Manley
Journal:  Oncologist       Date:  2017-04-13

2.  A Novel BRCA1 Gene Mutation Detected With Breast Cancer in a Vietnamese Family by Targeted Next-Generation Sequencing: A Case Report.

Authors:  Tran Van Thuan; Nguyen Van Chu; Pham Hong Khoa; Nguyen Tien Quang; Dao Van Tu; Nguyen Thi Quynh Tho; Phung Thi Huyen; Bui Hai Ha; Pham Thi Han; Duong Minh Long; Bach Thi Hoai Phuong
Journal:  Breast Cancer (Auckl)       Date:  2020-01-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.